John Delaney

Director, Research Technologies and Collaborations
John Delaney
John has a new unique role in Amgen Research, being responsible technology and innovation prospecting while developing, growing, and encouraging collaborations across the spectrum of Research disciplines. John joined Amgen in 1992 serving in various roles across the Protein Science and Biologics funtion, and most recently led Amgen’s Biologic Discovery function responsible for identifying large molecule therapeutic candidates in collaboration with all Amgen Therapeutic Areas, including the discovery of fully human antibody therapeutics. In 2010, John added the site leadership role for Amgen’s Burnaby, British Columbia research facility, managing the company’s significant protein science resources in Canada, and overseeing site administration. John holds a Bachelor of Science in Zoology from the University of Montana and earned his Ph.D. in the Department of Microbiology at the University of Arizona. He completed his postdoctoral training at the University of Utah’s Department of Cellular, Viral, and Molecular Biology working on the molecular biology of chaperones and bacterial thermotolerance.


No data was found

Other Speakers